Cleaner regulatory story
14/09/26 -"We keep a Buy on Pluxee as Brazilian PAT is priced in and, unlike Edenred, there is no antitrust file. However, we remain cautious on the turnaround, even if Pluxee trades at a discount. Business is ..."
Pages
59
Language
English
Published on
14/09/26
You may also be interested by these reports :
14/09/26
From bad to worse, the sector has jumped from one regulatory headwind to another during the last couple of years. Now that Edenred is roughly 50% up ...
14/09/26
We keep a Buy on Pluxee as Brazilian PAT is priced in and, unlike Edenred, there is no antitrust file. However, we remain cautious on the turnaround, ...
14/09/26
We upgrade our recommendation on Edenred from Reduce to Add as we believe most of the regulatory constraints are behind. Our €35 TP rests on a ...
10/09/26
sino AG has published good results again for Q3 26 (April-June 2026), underpinned by strong trading activity and commercial gains on the back of a ...